AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $365 | +2.2% | 5,229 | +5.2% | 0.00% | 0.0% |
Q2 2023 | $357 | +28.0% | 4,972 | +9.8% | 0.00% | +50.0% |
Q1 2023 | $279 | -31.4% | 4,529 | -14.2% | 0.00% | -50.0% |
Q4 2022 | $407 | -99.8% | 5,279 | +9.7% | 0.00% | +100.0% |
Q3 2022 | $215,000 | +23.6% | 4,812 | +5.7% | 0.00% | 0.0% |
Q2 2022 | $174,000 | -7.0% | 4,551 | +0.6% | 0.00% | +100.0% |
Q1 2022 | $187,000 | -47.2% | 4,525 | -13.8% | 0.00% | -66.7% |
Q2 2021 | $354,000 | +58.7% | 5,248 | +33.2% | 0.00% | -62.5% |
Q1 2021 | $223,000 | -36.8% | 3,940 | -9.0% | 0.01% | -38.5% |
Q4 2020 | $353,000 | +15.0% | 4,332 | +0.5% | 0.01% | 0.0% |
Q3 2020 | $307,000 | -15.9% | 4,310 | -2.8% | 0.01% | -23.5% |
Q2 2020 | $365,000 | +33.7% | 4,433 | -4.4% | 0.02% | +142.9% |
Q1 2020 | $273,000 | -42.4% | 4,635 | +1.0% | 0.01% | -22.2% |
Q4 2019 | $474,000 | – | 4,588 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |